| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/03/2001 | US6211170 Azetidinone derivatives for the treatment of HCMV infections |
| 04/03/2001 | CA2102772C Azetidinone compound and process for preparation thereof |
| 03/28/2001 | EP0775132B1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 03/27/2001 | US6207822 Reacting p-fluorobenzoylbutyric acid with pivaloyl chloride;acylation; reduction; cyclization; hydrosilation; deblocking |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/21/2001 | EP0681569B1 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 03/21/2001 | CN1063439C N-substituted 2-hetero cyclicbutanol |
| 03/20/2001 | US6204293 Inhibitors of protein isoprenyl transferases |
| 03/15/2001 | WO2001017956A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | CA2381581A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/14/2001 | EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 03/13/2001 | US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics |
| 03/13/2001 | US6200967 Used as thrombin inhibitors, coagulation inhibitors and agents for the treatment of thromboembolic disorders |
| 03/07/2001 | EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE |
| 03/06/2001 | US6197185 Process for preparing beta lactam compound |
| 02/28/2001 | EP1077700A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 02/28/2001 | EP1077695A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| 02/28/2001 | CN1285351A Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound |
| 02/27/2001 | US6194569 Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piperazinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | US6191146 Hemoregulatory compounds |
| 02/20/2001 | US6190852 Coupler provides a desirably narrow spectrographic absorption curve. |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/13/2001 | US6187916 Process for the preparation of taxane derivatives and β-lactam intermediates therefor |
| 02/13/2001 | US6187804 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1 -hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid, salt or hydrolysable ester thereof for example, dry blended with an alkali metal carbonate or bicarbonate |
| 02/01/2001 | WO2001007438A1 Enantioselective acylation of cis racemic azetidinones |
| 02/01/2001 | WO2001007043A1 Azetidine carboxamide derivatives for the treatment of cns disorders |
| 02/01/2001 | WO2001007023A2 Azetidine compounds in cns and eye diseases |
| 02/01/2001 | WO2001007022A2 Azetidine compounds in cns and eye diseases |
| 01/31/2001 | EP1071685A1 Titanium catalyzed preparation of carbapenem intermediates |
| 01/31/2001 | EP0842152B1 N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 01/24/2001 | CN1281433A Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors |
| 01/24/2001 | CN1061046C Process for preparing cephalosporins derivants |
| 01/18/2001 | WO2001004091A1 Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods |
| 01/17/2001 | EP0971889A4 Process for synthesizing carbapenem intermediates |
| 01/11/2001 | WO2001002426A1 A substantially crystalline form of melagatran |
| 01/11/2001 | CA2376944A1 A substantially crystalline form of melagatran |
| 01/10/2001 | EP1067136A1 New peptide derivatives |
| 01/03/2001 | CN1278821A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/02/2001 | US6169179 Method for manufacturing (3S,4R)-4-[(R)-1′-formylethyl]azetidin-2-one derivatives |
| 01/02/2001 | CA2054850C Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 12/27/2000 | EP1063230A1 Cyclic amino compounds |
| 12/26/2000 | US6166224 Method for racemization of optically active azetidine-2-carboxylate |
| 12/26/2000 | US6166056 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings |
| 12/26/2000 | US6165999 Tetracycline derivatives |
| 12/21/2000 | WO2000076964A1 Process for reduction of (2r)-4-oxoazetidinone-2-carboxylic acid |
| 12/21/2000 | CA2372182A1 Process for reduction of (2r)-4-oxoazetidinone-2-carboxylic acid |
| 12/19/2000 | US6162911 Crystalline imidazole complexes as carbapenem intermediates and synthesis |
| 12/12/2000 | US6160176 Anticoagulant agents |
| 12/12/2000 | US6160126 Useful in preparing guanidine derivatives useful as insecticides and miticides |
| 12/12/2000 | US6159973 Aromatic amides, their preparation process, the compositions containing them and their use as pesticides |
| 12/06/2000 | EP1057810A1 Method for producing n-protected-azetidine-2-carboxylic acids |
| 12/05/2000 | US6156903 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 12/05/2000 | US6156769 Antipruitus drugs for mammals |
| 11/30/2000 | WO2000071572A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 11/30/2000 | WO2000071518A2 Heterocyclic analgesic compounds and their use |
| 11/30/2000 | WO2000071511A2 INHIBITORS OF FACTOR Xa |
| 11/30/2000 | WO2000071510A2 INHIBITORS OF FACTOR Xa |
| 11/30/2000 | WO2000071508A2 INHIBITORS OF FACTOR Xa |
| 11/30/2000 | CA2374947A1 Inhibitors of factor xa |
| 11/30/2000 | CA2374793A1 Inhibitors of factor xa |
| 11/30/2000 | CA2374650A1 Inhibitors of factor xa |
| 11/30/2000 | CA2372887A1 Heterocyclic analgesic compounds and their use |
| 11/28/2000 | US6153747 Process for the preparation of 2-halomethyl-penems and their use for the preparation of antibacterial penems |
| 11/28/2000 | CA2172149C Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 11/23/2000 | WO2000069817A1 Process for producing optically active azetidine-2-carboxylic acids |
| 11/23/2000 | WO2000069816A1 Metabotropic glutamate receptor antagonists |
| 11/21/2000 | US6150535 Oxidation, reduction to give azetidine-2-methanol amine protection and oxidation |
| 11/21/2000 | US6150519 Multistage process with basification and ion exchanging then isolation an allene compound |
| 11/16/2000 | WO2000068193A1 New process |
| 11/16/2000 | WO2000012473A8 PROCESS FOR THE PRODUCTION OF N-PROTECTED AZETIDINE-2-CARBOXYLIC ACIDS (AzeOHs) |
| 11/14/2000 | US6147240 Isocyanoalkyl carbonic acid derivatives, their conversion into secondary amidoalkyl carbonic acid derivatives by isocyanide-multicomponent reactions, as well as these secondary amidoalkyl carbonic acid derivatives |
| 11/09/2000 | WO2000066557A1 New compounds |
| 11/08/2000 | EP1049672A1 Azetidinecarboxamide derivatives for treating cns disorders |
| 11/08/2000 | EP1049671A1 Azetidinecarboxamide derivatives for the treatment of cns disorders |
| 11/08/2000 | EP1049670A1 Azetidinecarboxamide derivatives for treating cns disorders |
| 11/08/2000 | CN1272841A Novel lactam metalloprotease inhibitors |
| 11/07/2000 | US6143903 Process for the production of enantiomerically-pure azetidine-2-carboxylic acid |
| 11/07/2000 | US6143554 Process for producing optically active n-substituted azetidine-2 carboxylic acid compound |
| 11/01/2000 | CN1271729A New beta-caprolactam, process for preparing taxane, and taxanes with side chain |
| 10/26/2000 | WO2000063168A1 Synthesis of azetidine derivatives |
| 10/25/2000 | CN1270958A Beta-lactan |
| 10/24/2000 | US6136591 Contacting a racemic n-acylazetidine-2-carboxylic acid ester with an enantiospecific enzyme to form enantiomerically enriched n-acylazetidine-2-carboxylic acid, an intermediate to azetidine-2-carboxylic acid and proline synthesis |
| 10/18/2000 | EP0850215B1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 10/17/2000 | US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity |
| 10/17/2000 | US6133253 3-Pyridyl enantiomers and their use as analgesics |
| 10/17/2000 | CA2001205C Antimicrobial quinolonyl lactams |
| 10/12/2000 | WO2000060107A1 Stereoselective microbial reduction for the preparation of 1 - (4-fluorophenyl) - 3(r)-[3(s) - hydroxy-3 - (4-fluorophenyl) propyl)]-4(s) - (4-hydroxyphenyl)-2-azetidinone |
| 10/12/2000 | WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
| 10/12/2000 | WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 10/12/2000 | CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
| 10/05/2000 | WO2000058283A1 Biocatalyst and its use in enzymatic resolution of racemic beta-lactams |
| 10/05/2000 | CA2360944A1 Biocatalyst and its use in enzymatic resolution of racemic beta-lactams |
| 10/04/2000 | CN1268937A Novel compound having effect of promoting neuron differentiation |
| 10/04/2000 | CN1057082C Method for prepn. of taxol |